Literature DB >> 10894297

Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein.

M Kano, T Matano, H Nakamura, A Takeda, A Kato, K Ariyoshi, K Mori, T Sata, Y Nagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10894297     DOI： 10.1097/00002030-200006160-00030

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen.

Authors:  T Matano; M Kano; H Nakamura; A Takeda; Y Nagai
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model.

Authors:  Kazuyasu Mori; Chie Sugimoto; Shinji Ohgimoto; Emi E Nakayama; Tatsuo Shioda; Shigeru Kusagawa; Yutaka Takebe; Munehide Kano; Tetsuro Matano; Takae Yuasa; Daisuke Kitaguchi; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; Naoki Yamamoto; Yasuo Suzuki; Yoshiyuki Nagai
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model.

Authors:  Akiko Takeda; Hiroko Igarashi; Hiromi Nakamura; Munehide Kano; Akihiro Iida; Takahiro Hirata; Mamoru Hasegawa; Yoshiyuki Nagai; Tetsuro Matano
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 4.  RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

Authors:  Juan A Bernal
Journal:  J Cardiovasc Transl Res       Date:  2013-07-13       Impact factor: 4.132

5.  First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.

Authors:  Julien Nyombayire; Omu Anzala; Brian Gazzard; Etienne Karita; Philip Bergin; Peter Hayes; Jakub Kopycinski; Gloria Omosa-Manyonyi; Akil Jackson; Jean Bizimana; Bashir Farah; Eddy Sayeed; Christopher L Parks; Makoto Inoue; Takashi Hironaka; Hiroto Hara; Tsugumine Shu; Tetsuro Matano; Len Dally; Burc Barin; Harriet Park; Jill Gilmour; Angela Lombardo; Jean-Louis Excler; Patricia Fast; Dagna S Laufer; Josephine H Cox
Journal:  J Infect Dis       Date:  2016-10-17       Impact factor: 5.226
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.